Showing 901 - 920 results of 1,115 for search '"heart failure"', query time: 0.07s Refine Results
  1. 901

    Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy by Marisa Ojala, Chandra Prajapati, Risto-Pekka Pölönen, Kristiina Rajala, Mari Pekkanen-Mattila, Jyrki Rasku, Kim Larsson, Katriina Aalto-Setälä

    Published 2016-01-01
    “…The clinical symptoms include arrhythmias, progressive heart failure, and even sudden cardiac death but the mutation carrier can also be totally asymptomatic. …”
    Get full text
    Article
  2. 902

    Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of Literature by Aleksey Novikov, Horatio Holzer, Robert A. DeSimone, Ghaith Abu-Zeinah, David J. Pisapia, Tomer M. Mark, Raymond D. Pastore

    Published 2015-01-01
    “…The patient was diagnosed with and treated for congestive heart failure but continued to suffer from hypercapnic respiratory insufficiency. …”
    Get full text
    Article
  3. 903

    Identifying Factors for Low-Risk Participation in Alternative Cardiac Rehabilitation Models for Patients with Coronary Heart Disease Using MI’S SCOREPAD by Eric J. Brandt, Joshua Garfein, Chih-Wen Pai, Joseph Bryant, Eva Kline-Rogers, Samantha Fink, Melvyn Rubenfire

    Published 2023-01-01
    “…Low-risk factors included not having any of the following: metabolic syndrome, presence of implantable cardioverter defibrillator or permanent pacemaker, active smoking, prior stroke, congestive heart failure, obesity, advanced renal disease, poor exercise capacity, peripheral arterial disease, angina, or clinical depression (MI’S SCOREPAD). …”
    Get full text
    Article
  4. 904

    Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy by Gen Suzuki, Rebeccah F. Young, Merced M. Leiker, Takayuki Suzuki

    Published 2016-01-01
    “…Thus, global infusion of CDCs could become a new therapy to reverse LV dysfunction in patients with asymptomatic heart failure.…”
    Get full text
    Article
  5. 905

    Acute Renal Failure and Volume Overload Syndrome Secondary to a Femorofemoral Arteriovenous Fistula Angioplasty in a Kidney Transplant Recipient by Dominique Bertrand, Geoffroy Desbuissons, Nicolas Pallet, Albane Sartorius, Christophe Legendre, Marie-France Mamzer, Rebecca Sberro Soussan

    Published 2013-01-01
    “…We report a case of a renal transplant recipient who developed an acute congestive heart failure accompanied by renal failure, which were triggered by femorofemoral AVF angioplasty. …”
    Get full text
    Article
  6. 906

    Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications by Ali A. Alshahrani, Evangelos Kontopantelis, Catharine Morgan, Rathi Ravindrarajah, Glen P. Martin, Mamas A. Mamas, Rongman Jia

    Published 2025-01-01
    “…Many chemotherapeutic agents used to treat cancer are associated with cardiovascular complications (such as heart failure, myocardial infarction, and thrombosis). …”
    Get full text
    Article
  7. 907

    New therapies in pulmonary arterial hypertension: Recent insights by Giulia Guglielmi, Konstantinos Dimopoulos, S. John Wort

    Published 2025-03-01
    “…Pulmonary Arterial Hypertension (PAH) is a complex and progressive disease characterized by elevated pulmonary vascular resistance and right heart failure. Current therapies primarily focus on pulmonary vasodilation; however, novel approaches that target the underlying pathophysiological mechanisms—such as TGF-β signalling, epigenetic alterations, growth factors, inflammation, and extracellular matrix remodelling—are promising alternatives for improving treatment outcomes. …”
    Get full text
    Article
  8. 908

    Cell autonomous TLR4 signaling modulates TGF-β induced activation of human cardiac fibroblasts by Gayathri Vijayakumar, Anisha Latha, Aiswaria P. Anil, Yogini Surve, Aiswarya R, Bipin G. Nair, Indulekha CL. Pillai

    Published 2025-02-01
    “…Using FACS, single-cell sequencing of cardiac fibroblasts from Collagen1-α1GFP mice and human heart failure patients, we demonstrate that TLR4 is the major immune sensor expressed in cardiac fibroblasts. …”
    Get full text
    Article
  9. 909

    The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial by Apirak Sribhutorn, Arintaya Phrommintikul, Wanwarang Wongcharoen, Usa Chaikledkaew, Suntara Eakanunkul, Apichard Sukonthasarn

    Published 2016-01-01
    “…The cardiovascular outcomes were described as major cardiovascular events (MACEs) which included mortality, hospitalization due to ACS, and hospitalization due to heart failure (HF). The stratified and multivariable Cox’s regression analysis was performed. …”
    Get full text
    Article
  10. 910

    A study on the global patterns in the design and development of ventricular assist devices: a visualization approach by Ajay K. Sood, A. K. Prasada Rao

    Published 2025-01-01
    “…IntroductionVentricular assist devices (VADs) are lifesavers for people with advanced heart failure. The design of these devices has undergone drastic changes over time with the latest designs being far more efficient, small, lightweight, and more user-friendly. …”
    Get full text
    Article
  11. 911

    Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Interve... by Shu-min Chang, Yan-tan Yu, Bo Luan, Ai-jie Hou, Yong Wang

    Published 2022-01-01
    “…Soluble growth stimulator gene 2 protein (sST2) is associated with heart failure and myocardial infarction; however, the predictive value of plasma sST2 level for coronary slow flow/no-reflow (CSF/NRF) is unclear. …”
    Get full text
    Article
  12. 912
  13. 913

    ICD Pocket-Site Infection Secondary to Gonococcal Bacteremia: The First Reported Case by Sardar Hassan Ijaz, Ali Haider Jafry, Areeba Shahnawaz, Mark Allee

    Published 2021-01-01
    “…A 56-year-old male with a history of congestive heart failure status postimplantable cardioverter-defibrillator (ICD) insertion presented with a pocket-site swelling initially concerning for a hematoma which began to exhibit erythema and tenderness. …”
    Get full text
    Article
  14. 914

    Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials by Armin Attar, Arman Karimi Behnagh, Mehrasa Hosseini, Foad Amanollahi, Paria Shafiekhani, Ali Kabir

    Published 2022-01-01
    “…However, these hemodynamic effects do not translate into a significant reduction in CTRCD incidence and prevention of hospitalization for heart failure or cardiac death.…”
    Get full text
    Article
  15. 915

    Self-management of non-communicable diseases in low- and middle-income countries: A scoping review. by Jason Hearn, Isaac Ssinabulya, Jeremy I Schwartz, Ann R Akiteng, Heather J Ross, Joseph A Cafazzo

    Published 2019-01-01
    “…The selected studies largely focused on the self-management of diabetes (N = 21), hypertension (N = 7) and heart failure (N = 5). Most interventions involved the use of short message service (SMS, N = 17) or phone calls (N = 12), while others incorporated educational sessions (N = 10) or the deployment of medical devices (N = 4). …”
    Get full text
    Article
  16. 916

    The First Autopsy Case of Fatal Acute Cardiac Failure after Administration of Carfilzomib in a Patient with Multiple Myeloma by Teruhito Takakuwa, Ippei Otomaru, Taku Araki, Akiko Miura, Yotaro Fujitani, Yasuhide Mochizuki, Yoshimi Miyagi, Hideto Senzaki, Ryosuke Yamamura

    Published 2019-01-01
    “…However, rapidly progressing fatal heart failure like in our case is rare. To characterize CFZ-associated CVAE, further case collection is needed.…”
    Get full text
    Article
  17. 917

    Surgical treatment of the concomitant pathology in corrected transposition of great arteries by O.Ye. Repin, L.S. Maniuc, V.I. Corcea, E.K. Cheptanaru, O.Ye. Maliga, E.I. Virlan, I.V. Cucu

    Published 2016-03-01
    “…Medical treatment of the progressive heart failure was prescribed to 48 years-old patient. …”
    Get full text
    Article
  18. 918

    One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study by Ayman Hammoudeh, Yousef Khader, Ramzi Tabbalat, Yahya Badaineh, Nazih Kadri, Haneen Shawer, Eyas Al-Mousa, Rasheed Ibdah, Batool A. Shawer, Imad A. Alhaddad

    Published 2022-01-01
    “…Independent predictors for all-cause mortality in patients with NVAF were age>75 years, heart failure, major bleeding event, type 2 diabetes mellitus, study enrollment as an in-patient, and coronary heart disease. …”
    Get full text
    Article
  19. 919

    Restoration of Sestrin 3 Expression Mitigates Cardiac Oxidative Damage in Ischemia–Reperfusion Injury Model by Mina Park, Sunghye Cho, Dongtak Jeong

    Published 2025-01-01
    “…In our previous research, we identified that miR-25 is significantly overexpressed in pressure overload-induced heart failure, and its inhibition improves cardiac function by restoring the expression of SERCA2a, a key protein involved in calcium regulation. …”
    Get full text
    Article
  20. 920

    Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography by Hugo Perazzo, Valdilea G. Veloso, Beatriz Grinsztejn, Chris Hyde, Rodolfo Castro

    Published 2015-01-01
    “…LSM might be influenced by nonfasting status, flare of transaminases, heart failure, extrahepatic cholestasis, presence of steatosis, aetiology of liver disease, type and position of probe, and operator’s experience. …”
    Get full text
    Article